Shifts in Womens Health: A Comprehensive Approach Matters The rise of GLP-1 medications reflects a deeper issue: womens health, especially in midlife, has been under-researched
Presence of established cardiovascular disease
Statements Author contributions SM, SP, MA, DeL, PK, SA, FN and JR conceived of the article, compiled the literature, and interpreted its contents
Semaglutide and Exercise Synergy in metabolic research models: Preserving Muscle Mass [PMID: 42449565] Laboratory literature summary: Semaglutide and Exercise Synergy in metabolic research models: Preserving Muscle Mass and Uncovering Organ Crosstalk
The clinical evidence for combining keto with GLP-1 therapy Research on this specific combination is still emerging, but the studies that do exist tell a compelling story
According to Belle Health safety information, these medications are contraindicated for individuals with: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN2) History of pancreatitis Known hypersensitivity to tirzepatide or any of its components Additionally, women who are pregnant, planning to become pregnant, or breastfeeding should not use tirzepatide